Cytosorbents Corporation
General ticker "CTSO" information:
- Sector: Health Care
- Industry: Medical - Devices
- Capitalization: $57.0M (TTM average)
Cytosorbents Corporation does not follow the US Stock Market performance with the rate: -27.0%.
Estimated limits based on current volatility of 3.3%: low 0.60$, high 0.64$
Factors to consider:
- Total employees count: 186 (-6.1%) as of 2023
- Top business risk factors: Liquidity and credit risks, Pandemic risks, Economic downturns and volatility, Manufacturing and commercialization risks, Regulatory and compliance
- Price in estimated range
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [0.51$, 1.16$]
- 2026-12-31 to 2027-12-31 estimated range: [0.57$, 1.25$]
Financial Metrics affecting the CTSO estimates:
- Positive: with PPE of -2.8 at the end of fiscal year the price was low
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -29.68 <= 0.07
- Positive: -4.45 < Investing cash flow per share per price, % of -1.00
Short-term CTSO quotes
Long-term CTSO plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $31.08MM | $35.59MM | $37.06MM |
| Operating Expenses | $63.03MM | $52.38MM | $51.30MM |
| Operating Income | $-31.95MM | $-16.79MM | $-14.24MM |
| Non-Operating Income | $1.89MM | $-5.62MM | $5.64MM |
| Interest Expense | $0.16MM | $1.40MM | $2.61MM |
| R&D Expense | $15.59MM | $6.92MM | $5.08MM |
| Income(Loss) | $-30.06MM | $-22.41MM | $-8.60MM |
| Taxes | $-0.81MM | $-1.69MM | $-0.40MM |
| Profit(Loss)* | $-29.99MM | $-20.72MM | $-8.20MM |
| Stockholders Equity | $23.28MM | $11.11MM | $5.90MM |
| Inventory | $3.68MM | $2.73MM | $5.28MM |
| Assets | $53.26MM | $47.37MM | $44.18MM |
| Operating Cash Flow | $-21.66MM | $-14.43MM | $-12.38MM |
| Capital expenditure | $0.94MM | $0.28MM | $0.16MM |
| Investing Cash Flow | $-0.94MM | $-0.67MM | $-0.41MM |
| Financing Cash Flow | $14.47MM | $9.33MM | $9.31MM |
| Earnings Per Share** | $-0.67 | $-0.38 | $-0.13 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.